Corcept Therapeutics
CORT
CORT
416 hedge funds and large institutions have $9.14B invested in Corcept Therapeutics in 2025 Q1 according to their latest regulatory filings, with 102 funds opening new positions, 127 increasing their positions, 141 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
416
Holders Change
+51
Holders Change %
+13.97%
% of All Funds
5.65%
Holding in Top 10
16
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+220%
% of All Funds
0.22%
New
102
Increased
127
Reduced
141
Closed
41
Calls
$193M
Puts
$335M
Net Calls
-$142M
Net Calls Change
-$127M
Top Buyers
| 1 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$68.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$61.7M |
| 3 |
Man Group
London,
United Kingdom
|
+$39M |
| 4 |
Morgan Stanley
New York
|
+$31.7M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$29.7M |
Top Sellers
| 1 |
BlackRock
New York
|
-$113M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
-$40.8M |
| 3 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$35.9M |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
-$33.3M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$33.1M |
